114 related articles for article (PubMed ID: 23032576)
1. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.
Gajjar K; Owens G; Sperrin M; Martin-Hirsch PL; Martin FL
Toxicology; 2012 Dec; 302(2-3):157-62. PubMed ID: 23032576
[TBL] [Abstract][Full Text] [Related]
2. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
5. Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.
Liu JY; Yang Y; Liu ZZ; Xie JJ; Du YP; Wang W
Mol Genet Genomics; 2015 Apr; 290(2):739-65. PubMed ID: 25475389
[TBL] [Abstract][Full Text] [Related]
6. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
7. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
Singh AP; Shah PP; Mathur N; Buters JT; Pant MC; Parmar D
Mutat Res; 2008 Mar; 639(1-2):11-9. PubMed ID: 18067928
[TBL] [Abstract][Full Text] [Related]
10. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.
Chen B; Qiu LX; Li Y; Xu W; Wang XL; Zhao WH; Wu JQ
Lung Cancer; 2010 Dec; 70(3):247-52. PubMed ID: 20395011
[TBL] [Abstract][Full Text] [Related]
11. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.
Xu W; Zhou Y; Hang X; Shen D
Mol Biol Rep; 2012 Mar; 39(3):2821-9. PubMed ID: 21674184
[TBL] [Abstract][Full Text] [Related]
12. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
13. Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.
Cui L; Dillehay K; Chen W; Shen D; Dong Z; Li W
Mol Biol Rep; 2012 Jul; 39(7):7465-71. PubMed ID: 22327650
[TBL] [Abstract][Full Text] [Related]
14. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.
Bhattacharjee A; Banerjee D; Mookherjee S; Acharya M; Banerjee A; Ray A; Sen A; ; Ray K
Mol Vis; 2008 May; 14():841-50. PubMed ID: 18483560
[TBL] [Abstract][Full Text] [Related]
15. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
Liu Y; Lin CS; Zhang AM; Song H; Fan CC
Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
[TBL] [Abstract][Full Text] [Related]
17. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].
Zimarina TC; Kristensen VN; Imianitov EN; Bershteĭn LM
Mol Biol (Mosk); 2004; 38(3):386-93. PubMed ID: 15285606
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the ERalpha and CYP1B1 genes in endometrial cancer in a Polish subpopulation.
Sliwinski T; Sitarek P; Stetkiewicz T; Sobczuk A; Blasiak J
J Obstet Gynaecol Res; 2010 Apr; 36(2):311-7. PubMed ID: 20492382
[TBL] [Abstract][Full Text] [Related]
19. Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.
Paracchini V; Raimondi S; Gram IT; Kang D; Kocabas NA; Kristensen VN; Li D; Parl FF; Rylander-Rudqvist T; Soucek P; Zheng W; Wedren S; Taioli E
Am J Epidemiol; 2007 Jan; 165(2):115-25. PubMed ID: 17053044
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.
Salinas-Sánchez AS; Donate-Moreno MJ; López-Garrido MP; Giménez-Bachs JM; Escribano J
J Urol; 2012 Feb; 187(2):700-6. PubMed ID: 22177211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
